| 16th Oct 2025 7:00 am |
RNS |
Fundraise & Transaction Update |
| 30th Sep 2025 7:00 am |
RNS |
Interim Results to 30 June 2025 |
| 24th Sep 2025 7:00 am |
RNS-R |
Investor Presentation via Engage Investor |
| 8th Sep 2025 7:00 am |
RNS |
Proposed Acquisition of Clinical Stage Company |
| 28th Aug 2025 7:00 am |
RNS |
Lyramid SPA 2nd Extension & Carve Out |
| 7th Jul 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 30th Jun 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Jun 2025 7:00 am |
RNS |
Lyramid SPA Extension |
| 26th Jun 2025 1:00 pm |
RNS |
Results of AGM |
| 13th Jun 2025 4:00 pm |
RNS |
Issue of Equity |
| 2nd Jun 2025 7:00 am |
RNS |
Notice of Annual General Meeting |
| 23rd May 2025 7:00 am |
RNS |
Extension of Convertible Loan Notes |
| 13th May 2025 7:00 am |
RNS |
Corporate Update |
| 30th Apr 2025 7:00 am |
RNS |
Annual Report & Financial Statements - 31 Dec 2024 |
| 14th Mar 2025 7:00 am |
RNS |
Private Placing and Conversion of CLNs |
| 10th Mar 2025 7:30 am |
RNS |
Board Changes |
| 10th Mar 2025 7:00 am |
RNS |
Proposed Sale of Oncogeni Ltd |
| 4th Mar 2025 7:00 am |
RNS |
Update on Sale of Lyramid |
| 4th Feb 2025 10:58 am |
RNS |
Director/PDMR Shareholding |
| 3rd Feb 2025 7:00 am |
RNS |
Share Purchase Agreement Signed - Sale of Lyramid |
| 2nd Jan 2025 7:00 am |
RNS |
Proposed Sale of Midkine Portfolio |
| 4th Dec 2024 4:00 pm |
RNS |
Director Share Distribution |
| 7th Nov 2024 7:00 am |
RNS |
Conversion of Convertible Loan Notes |
| 27th Sep 2024 7:00 am |
RNS |
Interim Results to 30 June 2024 |
| 23rd Sep 2024 7:00 am |
RNS |
Grant of Japan MK Cell Patent |
| 19th Sep 2024 7:00 am |
RNS |
STAT-6 siRNA Demonstrates Efficacy in Immunology |
| 2nd Sep 2024 7:00 am |
RNS |
Grant of MK Cell Patent & Licencing Update |
| 27th Jun 2024 12:46 pm |
RNS |
Results of AGM |
| 20th Jun 2024 7:00 am |
RNS |
Appointment of Broker |
| 4th Jun 2024 7:00 am |
RNS |
Notice of Annual General Meeting |
| 23rd May 2024 7:05 am |
RNS |
Issue of Convertible Loan Notes & Board Changes |
| 23rd May 2024 7:00 am |
RNS |
Midkine Antibody Licencing Deal |
| 26th Apr 2024 7:00 am |
RNS |
Annual Report & Financial Statements - 31 Dec 2023 |
| 5th Apr 2024 7:00 am |
RNS |
Response to Share Price Movement |
| 11th Mar 2024 7:00 am |
RNS |
Positive Results: Midkine mRNA and STAT-6 siRNA |
| 6th Feb 2024 7:00 am |
RNS |
Operations Update |
| 24th Nov 2023 7:00 am |
RNS |
Change of Auditor |
| 6th Nov 2023 7:00 am |
RNS |
Significant Mesodermal Killer Cell Milestone |
| 27th Sep 2023 7:00 am |
RNS |
Interim Results to 30 June 2023 |
| 22nd Sep 2023 11:42 am |
RNS |
Investor Presentation via Investor Meet Company |
